Nalaganje...
Radiopharmaceutical Validation for Clinical Use
Radiopharmaceuticals are reemerging as attractive anticancer agents, but there are no universally adopted guidelines or standardized procedures for evaluating agent validity before early-phase trial implementation. To validate a radiopharmaceutical, it is desirous for the radiopharmaceutical to be s...
Shranjeno v:
| izdano v: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7966985/ https://ncbi.nlm.nih.gov/pubmed/33747951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.630827 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|